Inside informationEnglish
Nicox and Kowa Sign Key Agreement worth up to €191.5 million for Exclusive Rights to Glaucoma Treatment NCX 470 in U.S. and all Unlicensed Territories
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Nicox SA
- Filed
- 17/07/2025, 07:30
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 118179_20250717